Needham downgrades Stryker to "hold" rating: 4 things to know

Spinal Tech

Needham has downgraded Stryker stock to a "hold" rating, according to an Analyst Ratings report.

Here are four things to know:

 

1. The company's stock currently has a consensus rating of "buy" and an average price target is $112.

 

2. Stryker's most recent report showed net sales were up slightly in the third quarter of 2015. The consolidated net sales were $2.4 billion in the third quarter, a 1.3 percent increase.

 

3. Michael Matson, analyst at Needham, stated "We have lowered our EPS estimates given a 2016 currency headwind of $0.10-$0.15."

 

4. However, corporate insider sentiment is positive on the stock, based on the recent corporate insider activity of 120 insiders.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers